Creative Drug Pricing Hindered By Medicaid Best Price, Stakeholders Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Requirement that drug manufacturers pay Medicaid rebates based on the best price available to any purchaser impedes payer efforts to negotiate value-based pricing for costly drugs, Pfizer and Express Scripts say.